Near Point-of-Care HIV Viral Load: Targeted Testing at Large Facilities

12Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Introduction:Point-of-care (POC) technologies in resource-limited settings can circumvent challenges of centralized laboratory testing, improving clinical management. However, higher device costs and uncertain indications for use have inhibited scaling up POC modalities. To address this gap, we investigated the feasibility and cost of targeted near-POC viral load (VL) testing in 2 large HIV clinics in Lilongwe, Malawi.Methods:VL testing using GeneXpert was targeted for patients suspected of treatment failure or returning to care after a previously elevated VL (>1000 copies/mL). Descriptive analysis of retrospective clinical and cost data is presented.Results:Two thousand eight hundred thirteen near-POC VL tests were conducted. One thousand five hundred eleven (54%) tests were for patients for whom results and reason for the test were documented: 57% (794/1389) of tests were to confirm a previously high VL, and 33% (462/1389) were due to clinical indications. Sixty-one percent (926/1511) of patients had a high VL, of whom 78% (719/926) had a recorded clinical action: 77% (557/719) switched to second line antiretroviral therapy, and 15% (194/719) were referred for intensive adherence counseling. Eighty-two percent (567/687) of patients received a clinical action on the same day as testing. The "all-in"cost was $33.71 for a valid POC VL test, compared with an international benchmark for a centralized VL test of $28.62.Conclusion:Targeted, near-POC VL testing was feasible and consistently enabled prompt clinical action. The difference between the "all-in"cost of near-POC VL and centralized testing of $5.09 could be further reduced in an optimized national program by combining targeted near-POC testing and centralized testing.

References Powered by Scopus

Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries

465Citations
N/AReaders
Get full text

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: What lessons have we learnt and how can we do better?

234Citations
N/AReaders
Get full text

Sustainable HIV treatment in Africa through viral-load-informed differentiated care

135Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities

10Citations
N/AReaders
Get full text

Costs of point-of-care viral load testing for adults and children living with hiv in kenya

9Citations
N/AReaders
Get full text

Development of a point-of-care assay for HIV-1 viral load using higher refractive index antibody-coated microbeads

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ganesh, P., Heller, T., Chione, B., Gumulira, J., Gugsa, S., Khan, S., … Phiri, S. (2021). Near Point-of-Care HIV Viral Load: Targeted Testing at Large Facilities. Journal of Acquired Immune Deficiency Syndromes, 86(2), 258–263. https://doi.org/10.1097/QAI.0000000000002555

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

46%

Researcher 12

43%

Lecturer / Post doc 2

7%

Professor / Associate Prof. 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

41%

Nursing and Health Professions 5

23%

Social Sciences 4

18%

Immunology and Microbiology 4

18%

Save time finding and organizing research with Mendeley

Sign up for free